Alternative Treatment for Cancer. için kapak resmi
Alternative Treatment for Cancer.
Başlık:
Alternative Treatment for Cancer.
Yazar:
Leung, Ping-Chung.
ISBN:
9789812709301
Yazar Ek Girişi:
Fiziksel Tanımlama:
1 online resource (384 pages)
Seri:
Annals of Traditional Chinese Medicine ; v.3

Annals of Traditional Chinese Medicine
İçerik:
Contents -- Contributors -- Preface to Series -- Preface to Volume 3 -- Chapter 1 The Scientific Basis of Chinese Medicine and Cancer Care: A Western Medicine Perspective Stephen M. Sagar & Raimond Wong -- 1.1 Introduction -- 1.2 Cancer as a Systemic Disease -- 1.3 The Body-Mind Network -- 1.4 Pharmacology of Chinese Herbs -- 1.5 Physiology of Acupuncture -- 1.6 Roles of TCM in Cancer Supportive Care -- 1.7 Conclusions -- Acknowledgments -- References -- Chapter 2 Recent Status and Outlook of Traditional Chinese Medicine in Cancer Treatment Dai-Han Zhou -- 2.1 Introduction -- 2.2 Methods -- 2.3 Results -- 2.4 Discussion -- References -- Chapter 3 Chinese Medicine and Cancer Treatment in Hong Kong: A General Review Ping-Chung Leung, Vincent Ooi, Eliza L.-Y. Wong, Wai-Chun Au, Chun-Kwok Wong, Wai-Kei Lam, Sing-Fai Leung & Tony S.-K. Mok -- 3.1 Introduction - Cancer and Ancient Chinese Medicine -- 3.2 Interest Over the Use of Herbs Against Cancer -- 3.3 A Practical Approach to the Clinical Use of Chinese Herbs for Cancer Patients -- 3.4 A Clinical Trial Using Herbal Preparation as Supplements to Chemotherapy for Cancer -- 3.5 A Clinical Trial Using a Herbal Formula as Supplement to Radiotherapy for Cancer Patients -- 3.6 A Clinical Trial Using Herbal Preparation as a Palliative Agent in the Treatment of Multiple Bone Metastases -- 3.7 A Clinical Trial Using Herbal Preparation as Preventive Agent for Immuno-Support -- 3.8 System Review of Effects of Coriolus on the Survival of Cancer patients -- 3.9 Conclusion -- References -- Chapter 4 Advancements of Ayurveda in Cancer Management with Special Focus on Hepatocellular Carcinoma Premalatha Balachandran -- 4.1 Introduction -- 4.2 Cancer Definition -- 4.2.1 Benign versus malignant tumors -- 4.2.2 Classification -- 4.2.3 Etiology -- 4.3 Ayurveda's Special Focus on Liver Diseases.

4.3.1 Description of liver -- 4.4 Neoplasm of the Liver -- 4.4.1 Hepatocellular carcinoma -- 4.4.1.1 Epidemiology -- 4.4.1.2 Pathogenesis and diagnosis -- 4.4.1.3 Treatment modalities in modern medicine -- 4.4.1.4 Basis for ayurvedic therapy -- 4.4.1.5 Ayurvedic treatment modalities -- 4.5 Anti-cancer Drugs of Ayurveda Meets Modern Science -- 4.5.1 Andrographis paniculata (Kalmegh) -- 4.5.2 Annona atemoya/ muricata (Sitaphala) -- 4.5.3 Boerhavia diffusa (Punarnava) -- 4.5.4 Eclipta alba (Bhringaraj) -- 4.5.5 Phyllanthus niruri /amarus (Bhumyamalaki) -- 4.5.6 Picrorrhiza kurroa (Katuki) -- 4.5.7 Podophyllum hexandrum (Giriparpata) -- 4.5.8 Tinospora cordifolia (Guduchi) -- 4.5.9 Semecarpus anacardium (Bhallataka) -- 4.5.10 Hepatoprotective ayurvedic formulations -- 4.6 Benefits and Risks of Ayurvedic Medicine in Cancer Care -- 4.7 Recommended Research Design -- 4.8 Conclusion -- References -- Chapter 5 Complementary Approaches to Cancer in Italy Ralph W. Moss -- 5.1 Introduction -- 5.1.1 The Di Bella affair -- 5.2 Methods -- 5.3 Results -- 5.3.1 A visit to Bologna -- 5.3.2 Santa Famiglia conference and LSA-CM -- 5.4 Discussion -- References -- Chapter 6 Kampo Treatment for Cancer Kenji Watanabe -- 6.1 Introduction -- 6.2 Prevention of Cancer -- 6.2.1 Shosaikoto ( ) for the prevention of the hepatocellular carcinoma -- 6.2.2 Shoseiryuto ( ) for the prevention of lung cancer -- 6.2.3 Shosaikoto ( ) for the prevention of melanoma -- 6.3 Treatment with Surgical Operation -- 6.3.1 Daikenchuto ( ) for the prevention of post-surgical ileus -- 6.4 Treatment with Chemotherapy -- 6.4.1 Saireito ( ) alleviates the side-effects of CDDP -- 6.4.2 Juzentaihoto ( ) alleviates the side-effects of CDDP -- 6.4.3 Hangeshashinto ( ) alleviates the side-effects of CPT-11 -- 6.5 Treatment with Irradiation.

6.5.1 Juzentaihoto for the hematopoiesis after irradiation -- 6.6 Prevention of Recurrence and/or Metastasis -- 6.6.1 Juzentaihoto for the prevention of colon cancer metastasis -- 6.7 Palliative Care -- 6.7.1 Daikenchuto for the constipation by morphine -- 6.8 Conclusion -- References -- Chapter 7 Risk Management of Complementary Alternative Medicines in Cancer Ursula Werneke -- 7.1 Introduction -- 7.2 Methods -- 7.3 Results -- 7.3.1 Potential modification of clinical course -- 7.3.1.1 Haematological cancers -- 7.3.1.2 Hormone sensitive cancers -- 7.3.2 Potential interactions with pharmacodynamics of conventional therapies -- 7.3.2.1 Antioxidants -- 7.3.2.2 Antifolates and folic acid -- 7.3.2.3 Endocrine therapies and immune therapies -- 7.3.3 Pharmacokinetic interactions -- 7.3.3.1 The CYP system -- 7.3.3.2 ABC transporters -- 7.3.4 Toxic effects -- 7.3.4.1 Vitamin C and methotrexate -- 7.3.4.2 Kava: alcohol or water extracts? -- 7.3.4.3 Pyrrolizidine alkaloids and hepatotoxicity -- 7.3.5 Potential interaction with nuclear medicine -- 7.4 Conclusions -- References -- Chapter 8 Complementary Therapies for Cancer Patients Barrie R. Cassileth, Jyothirmai Gubili & K. Simon Yeung -- 8.1 Introduction -- 8.2 The Prevalence of Complementary and Alternative Medicine (CAM) Therapies -- 8.2.1 CAM literature -- 8.2.2 Herbal remedies -- 8.3 Complementary Therapies -- 8.3.1 Mind-body techniques -- 8.3.2 Acupuncture -- 8.3.3 Massage therapy -- 8.3.4 Tai Chi -- 8.3.5 Music therapy -- 8.4 Summary -- References -- Chapter 9 Positive Findings about Herbs and Natural Products Action on Cancer Muriel J. Montbriand -- 9.1 Introduction -- 9.2 Comments about Herbs and Natural Products -- Acknowledgments -- References -- Chapter 10 Mechanistic Studies on Combination of Phytochemicals and Synthetic Drugs as Anti-Cancer Agents Shanmugam HemaIswarya & Mukesh Doble.

10.1 Introduction -- 10.2 AP1 and NF-kB Pathway -- 10.3 Receptor Tyrosine Kinase (RTK) Related Pathways of Signal Transduction -- 10.4 COX-2 and Cancer -- 10.5 Regulation of Cell Cycle -- 10.6 Modulation of Multi-Drug Resistance (MDR) -- 10.7 Alteration of Pharmacokinetics -- 10.8 Enhancement of Immune Function -- 10.9 Conclusion -- References -- Chapter 11 Ethnopharmacology Approaches for Botanical Immunomodulators and Chemoprotectants in Cancer Therapy Patwardhan Bhushan & Gautam Manish -- 11.1 Introduction -- 11.1.1 Cancer therapy: a case for multitarget approach and the role of botanicals -- 11.1.2 Adjuvant therapy: newer avenues -- 11.1.3 Natural products: discovery approaches -- 11.1.4 Ethnopharmacology: Ayurveda, Rasayana and immunomodulation -- 11.2 Material and Methods -- 11.2.1 Scope of botanicals -- 11.3 Results -- 11.3.1 Paraimmunity adjuvants: adaptogens or adjustive medicine -- 11.3.1.1 Botanicals with adaptogenic activity -- 11.3.1.2 Rasayana botanicals as adaptogens -- 11.3.2 Chemoprotection -- 11.3.2.1 Chemoprotection: drug targets and current trends -- 11.3.2.2 Botanical immunomodulators as chemoprotectants -- 11.3.2.3 Antioxidants in cytoprotection -- 11.3.3 Radioprotection -- 11.3.3.1 Radioprotectants from botanicals -- 11.3.4 Botanical Immunomodulators as anti-tumor agents -- 11.4 Discussion -- 11.4 Conclusion -- References -- Chapter 12 Bioactive Polysaccharides from TCM Herbs as Anti-Cancer Adjuvants Raymond Chang -- 12.1 Introduction -- 12.2 Bioactive Polysaccharides in Chinese Herbs -- 12.3 Immunomodulatory Property of Polysaccharides and the b-Glucan Receptor -- 12.4 Immunomodulatory Property of Polysaccharides and the Toll-Like Receptor (TLR) System -- 12.5 Polysaccharides as Anti-tumor Adjuvants -- 12.6 Immunomodulatory and Anti-tumor Polysaccharides in TCM.

12.7 Clinical Observations on Polysaccharides as Anti-cancer Adjuvants -- 12.8 Future Directions in the Development of Polysaccharides as Cancer Adjuvants -- References -- Chapter 13 Clinical Evaluation of Herbal Formula Decoction in Treating Non-Small Cell Lung Cancer by Various Rating Scales Jie You & Zhi-Ming Shi -- 13.1 Introduction -- 13.2 Material and Methods -- 13.2.1 Case selection criteria -- 13.2.1.1 Inclusion criteria -- 13.2.1.2 Exclusion criteria -- 13.2.1.3 Omission criteria -- 13.2.2 Clinical data -- 13.2.3 Treatment methods -- 13.2.4 Observation parameters and assessment criteria -- 13.2.4.1 Short-term therapeutic assessment -- 13.2.4.2 Quality of life -- 13.2.4.3 Symptoms -- 13.2.4.4 Toxicity and side-effects of chemotherapy -- 13.2.5 Statistics -- 13.3 Results -- 13.3.1 Short-term therapeutic effect -- 13.3.2 Quality of life -- 13.3.2.1 EORTC QLQ-LC43 scores in the combination and chemotherapy groups before and after treatment -- 13.3.2.2 FACT-L scores in the combination and chemotherapy groups before and after treatment -- 13.3.3 Changes in symptoms between the combination and chemotherapy groups before and after treatment -- 13.3.3.1 Comparison of symptoms between the combination and chemotherapy groups before and after treatment -- 13.4 Discussion -- References -- Chapter 14 New Approach for Evaluating the Anti-Breast Cancer Activity of Traditional Chinese Medicine John M. Pezzuto, Richard C. Moon, Charles K.-H. Chang & Ching-Jer Chang -- 14.1 Introduction -- 14.2 Selection of Traditional Chinese Medicine -- 14.3 Preparation and Quality Control of Complex Medicinal Formula -- 14.4 Animal Models for Breast Cancer -- 14.4.1 Maximum tolerated dose -- 14.4.2 N-Methyl-N-nitrosourea rat mammary -- 14.4.3 Transgenic mouse -- 14.5 Conclusions -- Acknowledgments -- References.

Chapter 15 Functional Magnetic Resonance Imaging Studies of Acupuncture Gary Deng & Barrie Cassileth.
Özet:
Cancer treatment has enjoyed half a century of healthy development, relying mainly on surgery, cytotoxic therapy and radiation. Achievements and successes are well reflected in the longer survival period and better quality of life. Nonetheless, cancer still spreads locally, recurs, metastasizes and remains one of the top killers. Instead of concentrating on cancer removal, it has become obvious that supportive measures are also important. These include the means to improve quality of life during treatment and to contain tumor growth. To this end, herbal medicine appears to offer holistic support via as yet unknown pathways. This volume reveals the practice of cancer treatment using herbs from all over the world, including China, India and Japan. It provides comprehensive information about the herbs commonly used, the logic of using the herbs, some of the mechanisms of action and other means of palliative treatment. While cancer victims have a thirst for choosing their own supplementary treatment, health providers have a duty to explain to them the justifications and the options. Sample Chapter(s). Chapter 1: The Scientific Basis of Chinese Medicine andCancer Care: A Western Medicine Perspective (272 KB). Contents: The Scientific Basis of Chinese Medicine and Cancer Care: A Western Medicine Perspective (S M Sagar & R Wong); Recent Status and Outlook of Traditional Chinese Medicine in Cancer Treatment (D-H Zhou); Chinese Medicine and Cancer Treatment in Hong Kong: A General Review (P-C Leung et al.); Advancements of Ayurveda in Cancer Management with Special Focus on Hepatocellular Carcinoma (P Balachandran); Complementary Approaches to Cancer in Italy (R W Moss); Kampo Treatment for Cancer (K Watanabe); Risk Management of Complementary Alternative Medicines in Cancer (U Werneke); Complementary Therapies for Cancer Patients (B R Cassileth et al.);

Positive Findings about Herbs and Natural Products Action on Cancer (M J Montbriand); Mechanistic Studies on Combination of Phytochemicals and Synthetic Drugs as Anti-Cancer Agents (S HemaIswarya and M Doble); Ethnopharmacology Approaches for Botanical Immunomodulators and Chemoprotectants in Cancer Therapy (P Bhushan & G Manish); Bioactive Polysaccharides from TCM Herbs as Anti-Cancer Adjuvants (R Chang); Clinical Evaluation of Herbal Formula Decoction in Treating Non-Small Cell Lung Cancer by Various Rating Scales (J You & Z-M Shi); New Approach for Evaluating the Anti-Breast Cancer Activity of Traditional Chinese Medicine (J M Pezzuto et al.); Functional Magnetic Resonance Imaging Studies of Acupuncture (G Deng & B Cassileth). Readership: Practitioners, educators, clinical and basic researchers, and health science students in traditional Chinese medicine; herbalists; cancer researchers; oncologists; clinicians in Western medicine; medical researchers; and pharmaceutical companies.
Notlar:
Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2017. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
Yazar Ek Girişi:
Elektronik Erişim:
Click to View
Ayırtma: Copies: